Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$30,261,219
+$4,561,949 QoQ
Shares Held
120,256
+1.8% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
1.12%
of 13F equity value
Holder Rank
#483
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Snowden Capital Advisors LLC holds $146,228,358 across 13 Drug Manufacturers - General names. ABBV ranks #2 (20.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
27,065 | $32,462,575 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
120,256 | $30,261,219 | |
| 3 | JNJ |
Johnson & Johnson
|
109,396 | $27,783,302 | |
| 4 | MRK |
Merck & Co., Inc.
|
145,291 | $18,669,893 | |
| 5 | AMGN |
Amgen Inc
|
39,480 | $14,296,497 | |
| 6 | AZN |
Astrazeneca PLC
|
42,309 | $8,022,632 | |
| 7 | NVS |
Novartis AG
|
22,603 | $3,542,342 | |
| 8 | PFE |
Pfizer Inc
|
125,051 | $3,011,228 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,261,219 | 120,256 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $25,699,270 | 118,163 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $27,122,219 | 118,702 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $21,893,727 | 94,557 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $17,826,944 | 96,040 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $20,174,471 | 96,289 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $17,474,307 | 98,336 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $23,002,075 | 116,478 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $21,888,867 | 127,617 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $25,829,974 | 141,845 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $19,441,141 | 125,451 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $18,839,693 | 126,390 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $17,424,496 | 129,329 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $19,759,648 | 123,986 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $19,696,057 | 121,874 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $15,825,237 | 117,914 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $14,802,760 | 96,649 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $14,704,998 | 90,710 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $9,060,697 | 66,918 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,049,043 | 74,618 | Shares | Sole | 2024-02-06 | |
| 2021-06-30 | $7,728,117 | 68,609 | Shares | Sole | 2024-01-08 | |
| 2021-03-31 | $6,700,008 | 61,911 | Shares | Sole | 2024-01-08 | |
| 2020-12-31 | $5,670,699 | 52,923 | Shares | Sole | 2024-01-08 | |
| 2020-09-30 | $4,492,841 | 51,294 | Shares | Sole | 2024-01-08 | |
| 2020-06-30 | $5,140,312 | 52,356 | Shares | Sole | 2024-01-08 | |
| 2020-03-31 | $3,339,026 | 43,825 | Shares | Sole | 2024-01-08 | |
| No filing history on record for this holder in this stock. | ||||||